The Fight Against Cancer

Cancer is the second leading cause of death globally, responsible for 8.8 million deaths in 2015, according to the World Health Organization (WHO), with approximately 70% of the fatalities occurring in low and middle-income countries.

cancer stats - subsahran africa

In 2012, Cipla announced a medical breakthrough that reduced prices of cancer drugs significantly. This discovery helped us provide affordable cancer treatment to more people across the world, especially those in countries like Africa.

The World without borders: Global collaboration for cancer care

Cipla has a strong association with the Clinton Health Access Initiative (CHAI), dating back to our collaboration for providing HIV treatment to countries in Sub-Saharan Africa for $1 a day in 2001. Given this history, CHAI approached us once again, for a three-way collaboration with the American Cancer Society (ACS), for providing  to expand access to life-saving cancer treatment to twenty countries in Sub-Saharan Africa, including Botswana, Mozambique, Cameroon, Namibia, Cote d’Ivoire, Democratic Republic of Congo, Ethiopia, Nigeria, Kenya, Uganda, Rwanda, Sierra Leone, Ghana, Swaziland, Lesotho, Liberia, Zambia, Malawi, Zimbabwe, Mauritius and Tanzania, which account for  most cancer cases in the region.

 

“While cancer treatments and the tools for early diagnosis are readily available in developed countries, market forces and other barriers have limited access in Africa. As was done for the HIV/AIDS crisis before it, this public-private collaboration will help revolutionise cancer treatment in sub-Saharan Africa and has the potential to save thousands of lives each year,” stated CHAI CEO, Ira Magaziner, in a press release issued to announce the collaboration.

Through this partnership, these African countries will gain access to 16 essential cancer medications, including chemotherapies. This will reduce reliance on middlemen and private distributors, help stabilise prices, streamline registration of products, and promote the entry of international suppliers with quality-approved products.  Moreover, through the implementation of these programs, African governments could move to cost-competitive, quality-approved medicines while halving current costs.

To help develop and sustain the volume pricing structure, ACS and CHAI are also working with IBM Health Corps, a pro bono consulting program, to develop and deploy ChemoQuant. ChemoQuant is a chemotherapy forecasting software which aims to help countries quantify their cancer medicine requirement and plan budgets and procurement. Uganda is now beginning to use the software, and five additional countries are expected to follow suit by the year’s end.

Cipla and the fight against cancer

Cipla’s association with CHAI dates back to over a decade ago when the two organisations got together to fight HIV/AIDS.

However, more than HIV/AIDS, cancer poses a greater threat in Africa due to lack of qualified cancer specialists and unavailability of low-cost medication. CHAI thus began screening global pharmaceutical companies for collaboration to manufacture and supply low-cost drugs directly to African governments and medical institutions.

Cipla was hand-picked by CHAI from a multitude of global pharmaceutical majors, given that all our drugs meet the SRA-WHO criteria (Stringent Regulatory Authority) and are US FDA or Europe Medicines Agency approved. The use of our own supply chain distribution network helped to significantly bring down costs, while safeguarding the high quality standards of our products. Moreover, we were able to provide these drugs to qualified medical specialists for effective administration of the cancer treatment.

Uganda and Ethiopia were the first two African countries to have approached us, and we are hopeful of more countries following suit, as word spreads about the availability of our affordable and high quality cancer treatment.  IBM is also helping us in this endeavor by identifying the requirement of drugs for the various kinds of cancers prevalent in the region.

Breathefree: Dispelling Myths About Asthma

Breathefree a public service initiative by Cipla was launched to create awareness about airway diseases such as asthma, COPD and allergic rhinitis.

As a part of the campaign to create awareness and dispell myths about asthma, Dr Raja Dhar, a leading pulmonologist in Kolkata talks about the taboo around the disease and how it can be managed effectively.

“There’s a lot of consciousness about chronic diseases like diabetes, heart diseases, hypertension and so on. There’s a distinct lack of consciousness regarding asthma. And I think if you look at the ads the way the programme is designed it will definitely increase consciousness about asthma. The second area it addresses is the taboos regarding asthma. So again going back to the advertisements, I think it addresses the key issues about calling asthma, asthma, being confident about the disease process and knowing about it and also being confident about using the main medication which is in the form of inhalation therapy. It also stresses the fact that if you take your medication regularly, if you are good in understanding how you need to manage the disease, then you will end up having perfect control and do what you want in everyday life including getting drenched in the rain for instance.”

“Its okay if you have asthma, you have control of the disease but make sure you exercise. Because inactivity further leads to inactivity of respiratory muscles which aggravates your asthma further, besides it leads to obesity which also worsens your breathlessness and reduces physical activity further. So you get into this vicious cycle – less activity-weight gain-obesity, obesity leading further reduction of daily activities and a further worsening of asthma.”

Cipla also launched a public awareness campaign called #BerokZindagi to sensitise people about asthma and other chronic respiratory diseases. The campaign aimed at destigmatising the use of inhalation therapy and make it socially acceptable.

For more such blogs follow us on TwitterFacebookLinkedIn.

Breathing New Life Into Asthma Care

In a country like India it is not surprising that breathing conditions such as asthma, wheezing, COPD and bronchitis abound. The air quality in many cities is not ideal and the dust and pollen in the air is every asthmatic’s nightmare. A large part of the population struggles with breathing difficulties, and myths and misconceptions about breathing conditions spread unabated.

Respiratory illnesses, despite being so common, still bear the brunt of social stigma because of the misconceptions around it. Even with 37 million asthmatics and 55 million COPD patients, the usage of asthma inhalers which is the most effective treatment is abysmally low at just 10%.

Blazing a trail

There have been several studies over the years on the prevalence of asthma and chronic obstructive pulmonary disease (COPD). The recent Global Burden of Disease Report from ICMR highlights the significant burden that these two diseases place on our economy.

As a pioneer in the field of respiratory medicine in India, Cipla connects with patients, providing more than just medicines. As a company that cares, we believe it is our responsibility to make relevant and credible information available to the public to erase the stigma around the illness and educate patients about the benefits of inhalers in asthma management.

With this in mind, Cipla rose to the challenge last year and launched BerokZindagi, a mass awareness campaign to educate patients, caregivers and the general population on the smartest ways to manage the illness. Cipla conducted a large-scale patient awareness and barriers study in late 2015, which formed the basis of BerokZindagi.

Learning to breathe free

Breathefree, is a long-standing patient support program from Cipla which offers comprehensive care for diagnosed patients. It is a one-of-a-kind support program where close to 600 patient counsellors touch 1.2 million patients every year and counsel them on the disease and its proper management.

Under the aegis of Breathefree, Cipla launched a mass awareness campaign, BerokZindagi, to tackle the patients’ myths and misconceptions around Asthma and inhalation therapy. The campaign has three main objectives; to educate people that: asthmatics can lead a fulfilling life, inhalation is a smart choice to manage asthma, and it is socially acceptable to be asthmatic and use inhalation as treatment.

 

#BerokZindagi: A breath of life

#BerokZindagi, our latest communication campaign focuses on awareness and education and the message is delivered through positivity and hope. We want to celebrate the fighting spirit of an asthmatic who overcomes odds every single day to live a #BerokZindagi. The campaign strives to establish inhalers as the smartest choice to combat the illness and eliminate stigma around asthma inhalers.

 

 

The #BerokZindagi campaign has used several channels to get the message across television ads and in-series integrations, cinemas, digital media, print and in-clinic and in-chemist communication. Cipla looks upon doctors and chemists as partners, and they assist us in actively reinforcing and furthering the communication of Breathefree.

The campaign was successfully integrated on television: two shows in Telugu, one show and a game show in Bengali, all of which delivered a significant incremental reach to our message. On the back of the successful run in AP/Telangana and West Bengal in FY18, the campaign will be scaled on a national level next year.
Cipla is probably the first in the country to connect with patients and start a conversation about asthma management on such a large scale.

The road ahead

The Breathefree initiative and the #BerokZindagi campaign have been extremely successful. The campaign has had a television reach of 30 million views in West Bengal and 47 million views in Andhra Pradesh and Telangana. It has had a digital reach of more than 9 million views and wide coverage in national and regional media.

We have received overwhelmingly positive feedback from all the stakeholders involved – doctors, patients, chemists, stockists and our own field force. We have over 100 doctor testimonials and as many patient testimonials appreciating and acknowledging the positive impact of the initiative.

Looking ahead, we intend to scale it up to a national level next year and spread the message of healthy breathing to a bigger group of people. Let’s breathe-free!

International Childhood Cancer Day: Cipla Foundation Fulfills Wishes Of Over 120 Paediatric Cancer Patients

International Childhood Cancer Day is commemorated in the world over on 15th Feb 2018 to raise awareness about childhood cancer and support children with cancer. Cipla Foundation partnered with Make A Wish Foundation to fulfil the wishes of over 120 paediatric patients suffering from serious illness at three different locations:  Mumbai, Pune and Bengaluru.

In Mumbai, a wish fulfilment drive was held at the Victoria Memorial School for the Blind. Dr YK Hamied and Rumana Hamied and volunteers from Cipla’s India Business team attended the drive. The Foundation fulfilled the wishes of over 50 children. Fun activities such as a drawing session, dance performance by a 9-year-old cancer survivor and Malkhamb were organised for the children.

In Bengaluru, over 60 children in the age group of 3 to 14 years were granted their wishes. Around 25 Ciplaites from API Manufacturing, Quality and Sales team volunteered for the cause at Kidwai Memorial Institute of Oncology, Bengaluru.

The Pune wish fulfilment drive was held at Cipla Palliative Care & Training Centre, Pune, and fulfilled wishes of 10 paediatric cancer patients. Dr Manjiri Dighe, the Centre’s Medical Director and Dr Vibha Bafna, Oncologist – Bharti Hospital, Pune, together with Cipla Foundation, handed over gifts such as bicycles, video games and dolls to the children. Members from Cipla’s India Business team and Pune Sales team also volunteered for the cause. The children and their families enjoyed the lunch and a fun magic show.

 

Impressed with the high standards at the Centre, Dr Bafna said in her speech, “A wonderful place, done up aesthetically, quiet and peaceful. Almost heaven-like for patients with huge problems. A great additional help to the city of Pune and to all clinicians like us. Thanks for inviting me.”

Our volunteer squad:

A big shout out to all our volunteers for coming together and making the day special and memorable for the children and their families.

Mumbai:- Jortin George, Dharmender Singh, Abhijit Nazare, Dr Omkar Bole, Sachin Khode, Deepak Mansukhani

Bengaluru: Channabasavaiah, Abhilash Jacob, Manish, Hariprasadh T, Ramkundleswar, Chiranjeevi,

Prabhakar, Daniel Boppuri, Jumat Kumar, Shylaja Krishnamurthy, C K Kulkarni, Lokesh

Kanchan Kitthur, Parameshwarappa, Pradeep T S, Suresh Amin, Nayana T D, P L Srinivas, Sandhya H M,

Rambabu, Veeresh, Mala, Vishwajeet, K Hemanth Kumar, Lalit Singh, Sujit Kumar

Pune: Kalpesh Dagwar, Maqsood Khan, Chanchalkumar G Gilda

Testimonials

Here’s what few of our volunteers had to say about the wish-fulfilment drive:

  • I was deeply touched by the cause and the huge vacuum that we have to fill. I will be glad to be associated with such initiatives and am honoured to be a volunteer.
  • The happiness and smiles the kids had on their faces brought tears to my eyes. It was a delight to volunteer at the Wish Fulfilment event. This was my first volunteering experience and I will cherish it for a lifetime. Hope to be part of such programs soon.
  • We could see smiles for those little moments among the children and their parents. We could understand the pain they were going through and we should do more such events to lend our hand in their hour of crisis. I was happy to bring hope and confidence to their lives in whichever small way possible.  Thank you for enabling us to be a part of this volunteering activity.

Make-A-Wish Foundation India, is a non-profit organization that started granting wishes in 1996 and since then has fulfilled over 48,500 wishes across 9 divisions in India. The Foundation is dedicated to granting the most cherished wish of children between the ages of 3 and 18 years, living with life-threatening illnesses, irrespective of their socio-economic status, caste, race or religion.

For more such blogs follow us on TwitterFacebookLinkedIn.

Cipla Brings Together A Dream Run Team For Tata Mumbai Marathon 2018

At Cipla, our purpose is ‘Caring For Life’ and Cipla Foundation takes this commitment beyond medicines to touch lives in the community. Cipla marathoners support the foundation’s cause every year at the Mumbai Marathon. In 2017, they officially carried our message at the Mumbai Marathon for the first time.

Here’s a glimpse of our debut at the Mumbai Marathon last year.

Tata Mumbai Marathon 2018

This year, Cipla has brought together a Dream Run team which will carry Cipla Foundation’s message of caring for life to the community.

Here’s Samina Vaziralli, Executive Vice Chairman, Cipla, on what it means for Cipla Foundation to be associated with Tata Mumbai Marathon 2018.

Rumana Hamied, CEO, Cipla Foundation, on what it means for Cipla Foundation to be associated with Tata Mumbai Marathon, 2018.

Here’s what few participants have to say about running for Cipla Foundation.

Here’s some action straight from the marathon.

 

For more such blogs follow us on Twitter, Facebook, LinkedIn.